Using the SuperNO2VA Device on a Patient With a Known Difficult Airway: A Case Report Facilitating Fiberoptic Intubation and Postoperative Nasal Positive Pressure

A&A Practice
Steven H CataldoNadia B Hensley

Abstract

Upper airway obstruction during anesthesia is the leading cause of complications during sedation, intubation, and emergence. Devices to support oxygenation and ventilation are costly, require capital equipment, and cannot be used during transport. We present a 46-year-old man with sleep apnea and anticipated difficult airway undergoing a cardiac ablation under general endotracheal intubation. The SuperNO2VA nasal mask provided high-flow nasal oxygen and positive pressure during awake fiberoptic intubation and on extubation, maintaining airway patency in the operating room, during transport, and in recovery. The SuperNO2VA is inexpensive and portable and should be considered for high-risk patients with difficult airways.

References

Apr 26, 2000·Anesthesiology·O LangeronB Riou
Apr 19, 2006·Annals of Internal Medicine·Valerie A LawrenceUNKNOWN American College of Physicians
Oct 27, 2006·Anesthesiology·Sachin KheterpalThomas A Ludwig
Dec 5, 2006·British Journal of Anaesthesia·J L BourgainA M Cros
Feb 1, 2013·Anesthesiology·Jeffrey L ApfelbaumUNKNOWN American Society of Anesthesiologists Task Force on Management of the Difficult Airway
Mar 21, 2013·Respiratory Care·Rachael L Parke, Shay P McGuinness
Jan 11, 2017·Anaesthesia and Intensive Care·L D WhiteL A Wallace

❮ Previous
Next ❯

Citations

Apr 10, 2020·International Anesthesiology Clinics·Adrian SultanaLauren Claire Berkow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.